Assignee
CSTONE PHARMACEUTICALS
KY·3 granted patents·2 pending applications·1 citations·filing 2016–2023
Top patents by PatentIndex Score
5 records- 0173US2024101676A1The novel monoclonal antibodies to programmed death 1 (pd-1)CSTONE PHARMACEUTICALS·Filed 2023·Application pending·0 cites
- 0272US11414487B2Monoclonal antibodies to programmed death 1 (PD-1)CSTONE PHARMACEUTICALS·Filed 2016·Granted Aug 16, 2022·1 cites·18 claims
- 0367US2023014722A1Novel Monoclonal Antibodies to Programmed DEATH (PD-1)CSTONE PHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 0444US10676474B21,6-naphthyridine derivatives as CDK4/6 inhibitorCSTONE PHARMACEUTICALS·Filed 2017·Granted Jun 9, 2020·0 cites·20 claims
- 0540US11021486B2Coumarin-like cyclic compound as MEK inhibitor and use thereofCSTONE PHARMACEUTICALS·Filed 2018·Granted Jun 1, 2021·0 cites·24 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →